Thursday 25 Apr 2024
By
main news image

SINGAPORE (Feb 22): Maybank Kim Eng, OCBC Investment Research, RHB Research and CGS-CIMB Research are maintaining their “buy” calls on Genting Singapore (GENS) with the respective target prices of S$1.26, S$1.31, S$1.22 and S$1.28.  

This comes after GENS’s latest set of FY18 financials fell slightly short of, or came in at the lower-end of the first three research houses’ expectations as they did consensus estimates, even as the group’s full-year earnings grew 10% to S$755.4 million from S$685.6 million a year ago.

In a Friday report, Maybank analyst Yin Shao Yang says he has trimmed core net profit estimates by 8% per annum due to higher depreciation & amortisation (D&A) forecasts, as GENS’s FY18 earnings came in at the lower-end of expectations due to... (Click here to read the full story)

      Print
      Text Size
      Share